Detalhe da pesquisa
1.
Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris.
J Drugs Dermatol
; 23(1): 1278-1283, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206145
2.
Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat.
J Drugs Dermatol
; 23(2): 42-49, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306147
3.
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel.
J Drugs Dermatol
; 23(3): 125-131, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443130
4.
Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies.
J Am Acad Dermatol
; 89(4): 719-727, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356627
5.
Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial.
J Am Acad Dermatol
; 89(5): 936-944, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172733
6.
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021.
J Eur Acad Dermatol Venereol
; 37 Suppl 1: 14-19, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546465
7.
Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis.
J Drugs Dermatol
; 22(8): 779-784, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556512
8.
Psoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis.
J Drugs Dermatol
; 22(8): 773-778, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556521
9.
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis.
J Drugs Dermatol
; 22(8): 736-741, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556522
10.
Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris.
J Drugs Dermatol
; 22(8): 810-816, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556524
11.
Post-Hoc Exploratory Pooled Analysis of the Impact of IDP-126 Gel on QoL in Moderate-to-Severe Acne.
J Drugs Dermatol
; 22(10): 1033-1039, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801539
12.
Janus kinase inhibitors in dermatology: Part II. A comprehensive review.
J Am Acad Dermatol
; 86(2): 414-422, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228996
13.
Janus kinase inhibitors in dermatology: Part I. A comprehensive review.
J Am Acad Dermatol
; 86(2): 406-413, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246698
14.
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
J Am Acad Dermatol
; 84(5): 1269-1277, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950546
15.
Update on Facial Erythema in Rosacea.
J Drugs Dermatol
; 20(8): 861-864, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397189
16.
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis.
J Am Acad Dermatol
; 83(1): 131-138, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430142
17.
Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris.
J Am Acad Dermatol
; 83(2): 477-485, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348828
18.
Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
J Am Acad Dermatol
; 82(5): 1166-1173, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32004648
19.
Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.
J Am Acad Dermatol
; 82(6): 1501-1510, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035944
20.
Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex.
J Drugs Dermatol
; 19(8): 777-783, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845584